Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002345258 | SCV002649408 | uncertain significance | Hereditary cancer-predisposing syndrome | 2020-07-31 | criteria provided, single submitter | clinical testing | The p.K185E variant (also known as c.553A>G), located in coding exon 3 of the MSH6 gene, results from an A to G substitution at nucleotide position 553. The lysine at codon 185 is replaced by glutamic acid, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000030276 | SCV000052943 | uncertain significance | Lynch syndrome | 2015-10-02 | no assertion criteria provided | clinical testing |